Swedish Orphan Bio S/Adr (SWTUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SWTUY | ITCI | BPMC | ||
Company | Swedish Orphan Bio S/Adr | Intra-Cellular Ther | Blueprint Medicines Corp | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 24.3800 | 66.88 | 107.00 | ||
High | 24.3800 | 66.88 | 107.17 | ||
Low | 24.3800 | 64.92 | 103.23 | ||
Last | 24.3800 | 65.00 | 104.96 | ||
Change | -0.2900 | -1.53 | -1.68 | ||
% Change | -1.18% | -2.30% | -1.58% | ||
Volume | 200 | 783,400 | 415,500 | ||
20-Day Average Volume | 1,450 | 848,345 | 712,060 | ||
Previous Close | 24.6700 | 66.53 | 106.64 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 23.1280 | 69.66 | 101.14 | ||
20-Day Raw Stochastic | 77.48% | 0.67% | 75.27% | ||
20-Day Relative Strength | 52.99% | 43.27% | 59.91% | ||
Weighted Alpha | N/A | +4.47 | +105.71 | ||
Today's Opinion | N/A | 8% Buy | 100% Buy | ||
Previous Opinion | N/A | 24% Buy | 100% Buy | ||
Last Month's Opinion | N/A | 88% Buy | 72% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -1.18% since 04/02/19 | +0.06% since 05/10/24 | -1.63% since 05/10/24 | ||
Low | 24.3800 on 04/09/19 | 64.92 on 05/17/24 | 103.23 on 05/17/24 | ||
High | 24.7500 on 04/08/19 | 68.16 on 05/15/24 | 111.02 on 05/14/24 | ||
1-Month | |||||
%Chg | +14.73% since 03/07/19 | -15.24% since 04/17/24 | +18.76% since 04/17/24 | ||
Low | 21.6200 on 03/12/19 | 64.92 on 05/17/24 | 84.62 on 04/19/24 | ||
High | 24.7500 on 04/08/19 | 76.89 on 04/23/24 | 111.02 on 05/14/24 | ||
3-Month | |||||
%Chg | +7.54% since 01/04/19 | -14.08% since 02/16/24 | +16.29% since 02/16/24 | ||
Low | 21.2500 on 03/07/19 | 62.78 on 02/22/24 | 80.42 on 02/22/24 | ||
High | 25.2900 on 01/18/19 | 84.89 on 04/16/24 | 111.02 on 05/14/24 | ||
6-Month | |||||
%Chg | -2.71% since 10/08/18 | +13.66% since 11/17/23 | +64.88% since 11/17/23 | ||
Low | 20.5000 on 10/31/18 | 56.83 on 11/20/23 | 63.50 on 11/20/23 | ||
High | 25.2900 on 01/18/19 | 84.89 on 04/16/24 | 111.02 on 05/14/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,643,745 | 7,023,904 | 6,526,368 | ||
Shares Outstanding, K | 272,508 | 105,575 | 61,200 | ||
Annual Sales | 763,720,000 | 464,370,000 | 249,380,000 | ||
Annual Net Income | 134,730,000 | -139,670,000 | -506,980,000 | ||
Last Quarter Sales | N/A | 144,870,000 | 96,120,000 | ||
Last Quarter Net Income | N/A | -15,250,000 | 89,140,000 | ||
60-Month Beta | 1.81 | 1.01 | 0.65 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.16 on 05/07/24 | -1.32 on 05/02/24 | ||
Latest Earnings Date | 04/25/19 | 05/07/24 | 05/02/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 25.97 | 0.00 | 0.00 |